Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Jon Lykkegaard Andersen; Jakob Sidenius Johansen; Edyta Maria Urbanska; Peter Meldgaard; Peter Hjorth-Hansen; Charlotte Kristiansen; Miroslaw Stelmach; Eric Santoni-Rugiu; Maiken Parm Ulhøi; Betina Højgaard; Morten Sall Jensen; Anders Bondo Dydensborg; Christina Dünweber; Karin Holmskov Hansen

doi:10.2217/lmt-2023-0013

Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen, Charlotte Kristiansen, Miroslaw Stelmach, Eric Santoni-Rugiu, Maiken Parm Ulhøi, Betina Højgaard, Morten Sall Jensen, Anders Bondo Dydensborg, Christina Dünweber, Karin Holmskov Hansen

Abstract

Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion: ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

Original language	English
Article number	LMT68
Journal	Lung Cancer Management
Volume	13
Issue number	1
Pages (from-to)	LMT68
ISSN	1758-1966
DOIs	https://doi.org/10.2217/lmt-2023-0013
Publication status	Published - 2024

Access to Document

10.2217/lmt-2023-0013Licence: CC BY

Cite this

Andersen, J. L., Johansen, J. S., Urbanska, E. M., Meldgaard, P., Hjorth-Hansen, P., Kristiansen, C., Stelmach, M., Santoni-Rugiu, E., Ulhøi, M. P., Højgaard, B., Jensen, M. S., Dydensborg, A. B., Dünweber, C., & Hansen, K. H. (2024). Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis. Lung Cancer Management, 13(1), LMT68. Article LMT68. https://doi.org/10.2217/lmt-2023-0013

Andersen, JL , Johansen, JS , Urbanska, EM, Meldgaard, P, Hjorth-Hansen, P, Kristiansen, C, Stelmach, M, Santoni-Rugiu, E, Ulhøi, MP, Højgaard, B, Jensen, MS, Dydensborg, AB, Dünweber, C & Hansen, KH 2024, 'Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis', Lung Cancer Management, vol. 13, no. 1, LMT68, pp. LMT68. https://doi.org/10.2217/lmt-2023-0013

@article{5a6d9c7fd7334fc2a983a81bfb5d5928,

title = "Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis",

abstract = "Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion: ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.",

author = "Andersen, {Jon Lykkegaard} and Johansen, {Jakob Sidenius} and Urbanska, {Edyta Maria} and Peter Meldgaard and Peter Hjorth-Hansen and Charlotte Kristiansen and Miroslaw Stelmach and Eric Santoni-Rugiu and Ulh{\o}i, {Maiken Parm} and Betina H{\o}jgaard and Jensen, {Morten Sall} and Dydensborg, {Anders Bondo} and Christina D{\"u}nweber and Hansen, {Karin Holmskov}",

note = "{\textcopyright} 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.",

year = "2024",

doi = "10.2217/lmt-2023-0013",

language = "English",

volume = "13",

pages = "LMT68",

journal = "Lung Cancer Management",

issn = "1758-1966",

publisher = "Future Medicine Ltd",

number = "1",

}

TY - JOUR

T1 - Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

AU - Andersen, Jon Lykkegaard

AU - Johansen, Jakob Sidenius

AU - Urbanska, Edyta Maria

AU - Meldgaard, Peter

AU - Hjorth-Hansen, Peter

AU - Kristiansen, Charlotte

AU - Stelmach, Miroslaw

AU - Santoni-Rugiu, Eric

AU - Ulhøi, Maiken Parm

AU - Højgaard, Betina

AU - Jensen, Morten Sall

AU - Dydensborg, Anders Bondo

AU - Dünweber, Christina

AU - Hansen, Karin Holmskov

PY - 2024

Y1 - 2024

N2 - Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion: ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

AB - Aim: The main purpose of the present study was to investigate the labor market affiliation of ALK+ NSCLC patients in long-term treatment as well as overall survival and incidence/prevalence. Materials & methods: Nationwide retrospective study of all patients with ALK+ NSCLC in Denmark diagnosed between 2012 and 2018. Results: During the study period ALK+ NSCLC patients had a median overall survival of 44.0 months and a 7.8-fold increase in disease prevalence. Six months prior to diagnosis, 81% of ALK+ NSCLC patients ≤60 years of age were employed. At the end of the 18-month follow-up period, 36% were employed. Conclusion: ALK+ NSCLC patients have prolonged survival following diagnosis, but a large fraction of patients lose affiliation with the labor market.

UR - http://www.scopus.com/inward/record.url?scp=85193511476&partnerID=8YFLogxK

U2 - 10.2217/lmt-2023-0013

DO - 10.2217/lmt-2023-0013

M3 - Journal article

C2 - 38818369

SN - 1758-1966

VL - 13

SP - LMT68

JO - Lung Cancer Management

JF - Lung Cancer Management

IS - 1

M1 - LMT68

ER -

Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this